JP2007505157A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007505157A5 JP2007505157A5 JP2006533147A JP2006533147A JP2007505157A5 JP 2007505157 A5 JP2007505157 A5 JP 2007505157A5 JP 2006533147 A JP2006533147 A JP 2006533147A JP 2006533147 A JP2006533147 A JP 2006533147A JP 2007505157 A5 JP2007505157 A5 JP 2007505157A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- pharmaceutical composition
- composition according
- nervous system
- steroid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47123503P | 2003-05-16 | 2003-05-16 | |
| PCT/US2004/015436 WO2004110355A2 (en) | 2003-05-16 | 2004-05-17 | Compositions and methods including a recombinant human mab that promotes cns remyelination |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007505157A JP2007505157A (ja) | 2007-03-08 |
| JP2007505157A5 true JP2007505157A5 (enExample) | 2007-10-25 |
Family
ID=33551425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006533147A Pending JP2007505157A (ja) | 2003-05-16 | 2004-05-17 | ＣＮＳ髄鞘再形成を促進する組換えヒトｍＡｂを含む組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (5) | US8460665B2 (enExample) |
| EP (1) | EP1648427B1 (enExample) |
| JP (1) | JP2007505157A (enExample) |
| AU (2) | AU2004247021A1 (enExample) |
| CA (2) | CA2525917C (enExample) |
| ES (1) | ES2451993T3 (enExample) |
| PL (1) | PL1648427T3 (enExample) |
| WO (1) | WO2004110355A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010509235A (ja) * | 2006-11-03 | 2010-03-25 | ノースウェスタン ユニバーシティ | 多発性硬化症の治療 |
| WO2009104100A2 (en) * | 2008-02-19 | 2009-08-27 | Patrys Limited | Antibody combinations, and methods of making and using same |
| WO2012054077A2 (en) | 2010-10-19 | 2012-04-26 | Mayo Foundation For Medical Education And Research | Human antibodies and diagnostic and therapeutic uses thereof for the treatment of neurological disease |
| WO2012149024A2 (en) | 2011-04-28 | 2012-11-01 | Mayo Foundation For Medical Education And Research | Dna aptamers for promoting remyelination |
| BR112014025898A2 (pt) | 2012-04-17 | 2017-11-07 | Mayo Found Medical Education & Res | anticorpos humanos e sequências de ligação específica, para uso em acidente vascular cerebral e isquemia ou condições isquêmicas |
| WO2016073963A1 (en) | 2014-11-07 | 2016-05-12 | Mayo Foundation For Medical Education And Research | Treatment of neonatal hypoxia including impairments or effects thereof |
| US11999778B2 (en) | 2016-05-13 | 2024-06-04 | The Board Of Regents Of The University Of Texas System | VH4 antibodies and compositions comprising the same |
| EP3401682A1 (en) * | 2017-05-09 | 2018-11-14 | Université de Nantes | Diagnosis, prevention and treatment of demyelinating disorders of the central nervous system |
| WO2020118218A1 (en) | 2018-12-06 | 2020-06-11 | Mayo Foundation For Medical Education And Research | Short dna aptamers and methods for promoting remyelination |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3167442D1 (en) | 1980-07-07 | 1985-01-10 | Nat Res Dev | Improvements in or relating to cell lines |
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4493795A (en) | 1983-10-17 | 1985-01-15 | Syntex (U.S.A.) Inc. | Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture |
| FR2556219B1 (fr) * | 1983-12-07 | 1987-06-26 | Merieux Inst | Nouveau medicament immunomodulateur, a base de fragments fc d'igg humaines |
| DE3825429C2 (de) | 1988-07-27 | 1994-02-10 | Biotest Pharma Gmbh | Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt |
| US5256771A (en) | 1990-04-03 | 1993-10-26 | Miles Inc. | Heat treatment of IgM-containing immunoglobulins to eliminate non-specific complement activation |
| US5591629A (en) * | 1994-04-29 | 1997-01-07 | Mayo Foundation For Medical Education & Research | Monoclonal antibodies which promote central nervous system remyelination |
| US7473423B2 (en) * | 1994-04-29 | 2009-01-06 | Mayo Foundation For Medical Education And Research | Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| EP2287190B1 (en) * | 2000-05-10 | 2014-12-17 | Mayo Foundation For Medical Education And Research | Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| JP2008127346A (ja) | 2006-11-22 | 2008-06-05 | Toshitsu Kagaku Kenkyusho:Kk | 自己免疫疾患、炎症および神経疾患を治療および予防するための医薬 |
-
2004
- 2004-05-17 CA CA2525917A patent/CA2525917C/en not_active Expired - Lifetime
- 2004-05-17 EP EP04752450.9A patent/EP1648427B1/en not_active Expired - Lifetime
- 2004-05-17 WO PCT/US2004/015436 patent/WO2004110355A2/en not_active Ceased
- 2004-05-17 CA CA2967294A patent/CA2967294C/en not_active Expired - Lifetime
- 2004-05-17 PL PL04752450T patent/PL1648427T3/pl unknown
- 2004-05-17 US US10/557,115 patent/US8460665B2/en not_active Expired - Fee Related
- 2004-05-17 ES ES04752450.9T patent/ES2451993T3/es not_active Expired - Lifetime
- 2004-05-17 AU AU2004247021A patent/AU2004247021A1/en not_active Abandoned
- 2004-05-17 JP JP2006533147A patent/JP2007505157A/ja active Pending
-
2010
- 2010-05-25 AU AU2010202111A patent/AU2010202111B2/en not_active Ceased
-
2013
- 2013-03-07 US US13/788,529 patent/US8968735B2/en not_active Expired - Lifetime
-
2015
- 2015-01-23 US US14/603,553 patent/US9751943B2/en not_active Expired - Fee Related
-
2017
- 2017-09-01 US US15/693,803 patent/US20180179277A1/en not_active Abandoned
-
2019
- 2019-09-23 US US16/578,649 patent/US20200247883A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Stanislaus et al. | Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin | |
| RU2018100129A (ru) | Способы лечения подагры | |
| Tanasescu et al. | Advances in the treatment of relapsing-remitting multiple sclerosis | |
| CA2624935A1 (en) | Anti-myostatin antibodies | |
| JP2005530490A5 (enExample) | ||
| JP2004517611A5 (enExample) | ||
| CN108368121A (zh) | 制备(3S，4R)-3-乙基-4-(3H-咪唑并[1，2-a]吡咯并[2，3-e]吡嗪-8-基)-N-(2，2，2-三氟乙基)吡咯烷-1-甲酰胺及其固态形式的方法 | |
| JP2005523946A5 (enExample) | ||
| TW200803895A (en) | Method of using IL6 antagonists with proteasome inhibitors | |
| JP2014114288A5 (enExample) | ||
| RU2011110169A (ru) | Антитела против ccr2 | |
| Heck et al. | Pharmacological therapy of bronchial asthma: the role of biologicals | |
| JP2005533001A5 (enExample) | ||
| JP2009511480A5 (enExample) | ||
| JP2003517461A5 (enExample) | ||
| JP2004510752A5 (enExample) | ||
| JP2013532181A5 (enExample) | ||
| CA2568352A1 (en) | Methods of using il-1 antagonists to treat autoinflammatory disease | |
| RU2009120202A (ru) | Способы и композиции для лечения и мониторинга лечения связанных с il-13 расстройств | |
| JP2005505256A5 (enExample) | ||
| JP2012504602A5 (enExample) | ||
| JP2006506942A5 (enExample) | ||
| JP2021520393A5 (enExample) | ||
| JP2006511620A5 (enExample) | ||
| JP2022512635A (ja) | Ｔｆｐｉアンタゴニストのための投薬レジメン |